Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

161 Results
Title Activity Code Posting Date Expiration Date Sort descending
Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)- RFA-AI-22-012 U01 February 24, 2022 July 02, 2022
Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)- RFA-AI-22-020 UH2/UH3 April 05, 2022 July 02, 2022
Notice of Special Interest—Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data- NOT-PM-22-002 Supp May 20, 2022 July 06, 2022
Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)- RFA-AI-22-016 R01 March 02, 2022 July 09, 2022
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)- PAR-20-153 R25 March 30, 2020 July 14, 2022
Limited Competition Emergency Awards—Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)- PAR-21-276 S10 July 16, 2021 July 16, 2022
Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-106 P30 February 03, 2020 July 29, 2022
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-107 P30 February 03, 2020 July 29, 2022
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)- PAR-20-158 R01 March 31, 2020 July 29, 2022
Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)- RFA-AI-22-028 R01 April 05, 2022 July 30, 2022
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 R61/R33 March 10, 2022 August 04, 2022
Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 R01 March 29, 2022 August 04, 2022
Limited Interaction Targeted Epidemiology—Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)- RFA-AI-22-024 UG3/UH3 April 13, 2022 August 04, 2022
Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed) - RFA-NS-22-051 U2C June 06, 2022 August 11, 2022
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)- PAR-20-108 R01 February 04, 2020 August 20, 2022
Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)- RFA-ES-22-003 U24 June 06, 2022 August 26, 2022
Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 R01 October 24, 2019 September 08, 2022
NIAID Investigator-Initiated Program Project Applications (P01 Clinical Trial Not Allowed)- PAR-20-072 P01 December 09, 2019 September 08, 2022
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)- PAR-20-231 K01 June 16, 2020 September 08, 2022
Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)- RFA-AI-22-034 R01 May 12, 2022 September 13, 2022
Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 R01 May 10, 2022 September 15, 2022
Limited Competition—A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)- RFA-CA-22-026 U24 June 14, 2022 September 16, 2022
Limited Competition—Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)- PAR-22-056 U42 November 03, 2021 September 26, 2022
Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)- RFA-DK-21-021 R43/R44 June 25, 2021 October 08, 2022
A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed)- RFA-AI-22-038 P01 May 27, 2022 October 14, 2022